ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

CITC 2024 – D1S02 – Basics of Clinical Trial Design

Автор: U.S. Food and Drug Administration

Загружено: 2025-08-19

Просмотров: 909

Описание: Learn the essential principles behind rigorous clinical research that supports FDA drug approvals. This video covered the key elements that make clinical studies reliable and scientifically sound, including what makes a study "adequate and well-controlled" according to FDA standards. Explore why control groups are critical for determining drug effectiveness, examine different types of controls used in clinical investigations, and discuss proven methods researchers use to minimize bias and ensure objective results.

Timestamps

00:34 – Adequate & Well-Controlled Studies

05:33 – Purpose of Control Groups

18:13 – Methods of Assignment to Study Arms

23:03 – Measures to Reduce Bias

27:37 – Assessing Response / Endpoints

32:53 – Intercurrent Events

43:22 – Other Design Considerations

47:49 – Summary

Speaker:

James P. Smith, MD, MS
Director
Office of New Drug Policy (ONDP)
Office of New Drugs (OND)
CDER | FDA

Learn more at: https://www.fda.gov/drugs/news-events...

-----------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2024 Playlist -    • 2024 CDER Small Business and Industry Assi...  
SBIA 2025 Playlist -    • 2025 CDER Small Business and Industry Assi...  
SBIA LinkedIn -   / cder-small-business-and-industry-assistance  
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter -   / fda_drug_info  
Email - [email protected]
Phone - (301) 796-6707 I (866) 405-5367

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
CITC 2024 – D1S02 – Basics of Clinical Trial Design

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

CITC 2024 – D1S03 – Statistical Principles for Clinical Development

CITC 2024 – D1S03 – Statistical Principles for Clinical Development

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women

A Deep Dive: FDA’s Model-Integrated Evidence (MIE) Industry Meeting Pilot Program for Generic Drugs

A Deep Dive: FDA’s Model-Integrated Evidence (MIE) Industry Meeting Pilot Program for Generic Drugs

FDA Direct: This Week at the FDA!

FDA Direct: This Week at the FDA!

FDA Clinical Investigator Training Course (CITC) 2022, Day 1 – Part 1

FDA Clinical Investigator Training Course (CITC) 2022, Day 1 – Part 1

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

mRNA COVID Shots Cause Myocarditis

mRNA COVID Shots Cause Myocarditis

Medical Device Quality Management System Regulation Design and Development

Medical Device Quality Management System Regulation Design and Development

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Direct: Citrus Regs, Natural Dye Pledges, and Hidden Opioids

FDA Direct: Citrus Regs, Natural Dye Pledges, and Hidden Opioids

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA Direct: Stanford Physician-Scientist: FDA welcomes Dr. Tidmarsh as CDER Director

FDA Direct: Stanford Physician-Scientist: FDA welcomes Dr. Tidmarsh as CDER Director

FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy

FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy

REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)

REdI 2024 | D1S05 - The CDER Center for Clinical Trial Innovation (C3TI)

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

Center Director’s Decision Memo

Center Director’s Decision Memo

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]